The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Share News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,846.00
Bid: 1,826.00
Ask: 1,840.00
Change: 0.00 (0.00%)
Spread: 14.00 (0.767%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,846.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genus Posts "Very Strong" Interim Results Despite Covid-19 Impact

Thu, 25th Feb 2021 09:42

(Alliance News) - Genus PLC on Thursday reported a "very strong" performance" and made "good" strategic progress in the first half of its 2021 financial year.

The Basingstoke, Hampshire-based company sells products made using biotechnology to cattle and pig farmers. It recorded revenue for the six moths ended December 31 of GBP285.7 million, a rise of 6% from GBP270.7 million in 2019.

Pretax profit for the period was GBP38.7 million, a substantial increase of 27% from GBP30.4 million in 2019.

Genus said these increases are due to a "strong" revenue growth of 6% in actual currency and 11% in constant currency. Its porcine genetics business saw an 8% increase, while its bovine genetics business grew by 17%, particularly in Brazil, Russia, India and China.

As a result of "strong earnings growth and cash flow generation", the company has declared an interim dividend of 10.3 pence, which is a 10% increase from 9.4p the previous year.

Shares in Genus were down 4.9% at 4,984.98p in London on Thursday.

"The group continued to show its resilience during the Covid-19 pandemic. Both PIC and ABS grew adjusted operating profits in double digits, with China, Brazil, India and Russia, being notably high growth markets. The porcine genetics business' expansion in China was significant, gaining share with large producers that have been re-stocking following the spread of African Swine Fever in 2019. Europe's growth was also very strong reflecting success with key accounts, leveraging our genetics and supply chain," said Chief Executive Stephen Wilson.

"The bovine genetics business' volume growth in the half was a record, driven by the continued success of Sexcel, and strong performance by our proprietary NuEra beef business. Latin America, Europe and Asia all grew strongly, and ABS's adjusted operating margin improved through better product mix and operating leverage," Wilson added.

Looking ahead, Genus said it will remain "resilient" as the the Covid-19 pandemic continues and expects trading to be in line with its 2021 expectations.

"In the second half of the 2021 fiscal year, we expect that growth will be lower and there are increased currency headwinds. Nevertheless, Genus continues to have significant growth opportunities and the board's expectations remain unchanged for the full year," Wilson said.

By Zoe Wickens; zoewickens@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
24 Nov 2021 09:56

Genus shares slump 13% due to Chinese pig market challenges

Genus shares slump 13% due to Chinese pig market challenges

Read more
24 Nov 2021 09:13

LONDON MARKET OPEN: US President Biden unable to stop rising oil price

LONDON MARKET OPEN: US President Biden unable to stop rising oil price

Read more
24 Nov 2021 07:54

Genus sees FY profit 'moderately' below its expectations

(Sharecast News) - Animal genetics company Genus said on Wednesday that based on current trading, especially in China, pre-tax profit for 2022 is set to be "moderately lower" than its previous expectations.

Read more
17 Nov 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
11 Nov 2021 15:49

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
15 Sep 2021 09:39

LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC

LONDON BROKER RATINGS: HSBC lifts Compass to Buy; RBC cuts JTC

Read more
14 Sep 2021 19:36

IN BRIEF: Genus Chief Executive Wilson sells GBP1.1 million in shares

IN BRIEF: Genus Chief Executive Wilson sells GBP1.1 million in shares

Read more
9 Sep 2021 17:02

LONDON MARKET CLOSE: Stocks fall as China factory gate inflation jumps

LONDON MARKET CLOSE: Stocks fall as China factory gate inflation jumps

Read more
9 Sep 2021 12:08

LONDON MARKET MIDDAY: FTSE 100 tumbles as mood sours ahead of ECB

LONDON MARKET MIDDAY: FTSE 100 tumbles as mood sours ahead of ECB

Read more
9 Sep 2021 09:37

LONDON BROKER RATINGS: Credit Suisse raises boohoo; Peel cuts Genus

LONDON BROKER RATINGS: Credit Suisse raises boohoo; Peel cuts Genus

Read more
9 Sep 2021 09:20

TOP NEWS: Genus may not meet medium-term goals, despite earnings rise

TOP NEWS: Genus may not meet medium-term goals, despite earnings rise

Read more
9 Sep 2021 08:42

LONDON MARKET OPEN: FTSE falls as ECB tapering feared; easyJet tumbles

LONDON MARKET OPEN: FTSE falls as ECB tapering feared; easyJet tumbles

Read more
9 Sep 2021 07:48

LONDON MARKET PRE-OPEN: Morrisons profit falls; Genus sees volatility

LONDON MARKET PRE-OPEN: Morrisons profit falls; Genus sees volatility

Read more
9 Sep 2021 07:36

Genus posts rise in FY profits but warns over hit to growth

(Sharecast News) - Animal genetics company Genus reported a jump in full-year profit and revenue on Thursday as it continued to win new customers, with growth in both of its business, but warned that recent volatility in the Chinese porcine market will dent growth.

Read more
2 Sep 2021 14:55

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.